Sign in now to see personalised content appear here.
You can also see your reading history and subscription details on your subscriber page.
The shift from small molecules to large molecules, such as antibodies and proteins, has created new opportunities in the pharmaceutical industry
Agreement combines BioAtla's conditionally active biologic (CAB) antibodies with Pfizer's proprietary ADC payloads
To help improve productivity and simplify the purification process
Detailed validation protocols streamline optimisation and validation, saving time and reagents
Cobra developed the cell line to express agonistic CD40 antibodies for an immuno-oncology application using its maxXpress platform
CiteAb lists more than 1.5 million antibodies from 92 suppliers
Using Wacker E.coli-based ESETEC secretion technology